PlainRecalls
FDA Drug Moderate Class II Terminated

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

Reported: March 3, 2021 Initiated: February 17, 2021 #D-0288-2021

Product Description

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

Reason for Recall

Lack of Assurance of Sterility

Details

Units Affected
50 mL vial
Distribution
Product was distributed to one direct account.
Location
Boston, MA

Frequently Asked Questions

What product was recalled?
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50. Recalled by The General Hospital Corporation. Units affected: 50 mL vial.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on March 3, 2021. Severity: Moderate. Recall number: D-0288-2021.